Oral delivery of a highly stable superoxide dismutase as a skin aging inhibitor - 17/06/23
Abstract |
As an effective antioxidant enzyme, superoxide dismutase (SOD) has been widely used as a food supplement, cosmetic additive, and therapeutic agent. However, oral delivery of SOD is challenging due to its relative instability, limited bioavailability, and low absorption efficiency in the gastrointestinal (GI) tract. We addressed these issues using a highly stable superoxide dismutase (hsSOD) generated from a hot spring microbial sample. This SOD exhibited a specific activity of 5000 IU/mg while retaining its enzymatic activity under low pH environments of an artificial GI system and in the presence of surfactants and various proteolytic enzymes. The inhibitory effects of hsSOD against skin-aging was evaluated under both in vitro and in vivo experiments using fibroblast cell and D-galactose induced aging-mouse models, respectively. Effective oral delivery of hsSOD promises wide applicability in pharmaceutical and food industries.
Le texte complet de cet article est disponible en PDF.Highlights |
• | A highly stable SOD (hsSOD) enzyme proves feasible for oral administration. |
• | High absorption and therapeutic efficacy were demonstrated. |
• | The therapeutic hsSOD shows promise in the prevention of skin-aging. |
Abbreviations : SOD, hsSOD, ROS, GSH, MDA, HYP, SGF, SIF, SB, AST, ALT, UA, CREA, OS, GI, D-gal, EDTA, BSA, ABTS, NBT, SA-β-gal, IPTG, MWCO, Vit C, GAPDH
Keywords : Skin aging, Superoxide dismutase, Oral delivery, Antioxidant, Bioavailability
Plan
Vol 164
Article 114878- août 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?